Chris Chuckran

Chris Chuckran, PhD, currently serves as an Immune Monitoring Specialist at Immudex, focusing on Dextramer-based reagents for characterizing antigen-specific immune responses for therapeutic applications. Previously, Chris held the position of Field Application Scientist at LUMICKS, supporting cancer cell therapy research. As the CEO and Vice President of Business Development at Fourth River Solutions, Chris significantly increased revenue through new project acquisitions. Experience also includes a consultant role at Hitachi Consulting, a summer internship at Bristol-Myers Squibb, and research positions at MD Anderson Cancer Center and Rice University. Chris earned a PhD in Immunology from the University of Pittsburgh School of Medicine and a BS in Bioengineering and Biomedical Engineering from Rice University.